| | | | | |
AGIO Agios Pharmaceuticals, Inc. | $29,0050 | +4,79% | $1,74B | $183,65K | |
SGRY Surgery Partners, Inc. Common Stock | $13,6960 | +1,38% | $1,74B | $489,49K | |
GAB The Gabelli Equity Trust Inc. | $5,5950 | -0,27% | $1,74B | $640,50K | |
HURN Huron Consulting Group Inc. | $107,56 | +2,62% | $1,74B | $36,89K | |
ENVX Enovix Corporation Common Stock | $8,2840 | +0,66% | $1,74B | $3,31M | |
PAYO Payoneer Global Inc. Common Stock | $5,1750 | +1,67% | $1,74B | $1,33M | |
ETV Eaton Vance Tax-Managed Buy-Write Opportunities Fund | $14,9400 | +0,20% | $1,73B | $112,94K | |
STGW Stagwell Inc. Class A Common Stock | $6,6350 | +0,68% | $1,73B | $399,12K | |
CASH Pathward Financial, Inc. Common Stock | $78,8100 | +1,38% | $1,73B | $71,04K | |
SNDX Syndax Pharmaceuticals, Inc. | $17,8710 | -2,56% | $1,73B | $4,87M | |
STRA Strategic Education, Inc. Common Stock | $81,1250 | +2,63% | $1,73B | $82,54K | |
CAPR Capricor Therapeutics Inc | $28,1200 | +1,74% | $1,73B | $232,17K | |
AAPG Ascentage Pharma Group International American Depository Shares | $18,4200 | +3,08% | $1,73B | $1,74K | |
SLS SELLAS Life Sciences Group, Inc. Common Stock | $8,8850 | +8,49% | $1,73B | $4,25M | |
PLSE Pulse Biosciences, Inc Common Stock (DE) | $27,5000 | +10,04% | $1,73B | $307,78K | |
